Narcolepsy Drugs Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028
Market Overview:
The global narcolepsy drugs market size reached US$ 3.1 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 4.8 Billion by 2028, exhibiting a growth rate (CAGR) of 7.51% during 2023-2028.
Narcolepsy drugs refer to pharmaceutical medicines used for the treatment of chronic sleep disorders. The disorder is characterized by excessive daytime sleepiness (EDS), cataplexy or sudden loss of muscle strength, sleep paralysis, hallucinations, fragmented sleep and insomnia. Additional symptoms may include automatic behaviors without conscious awareness, blurred vision, double vision or droopy eyelids and disturbed mental functioning. Patients suffering from narcolepsy tend to sleep the same number of hours per day as normal individuals; however, sleep quality tends to be poorer. Some of the commonly used narcolepsy drugs include central nervous system stimulants, sodium oxybate, selective serotonin reuptake inhibitors and tricyclic antidepressants. These drugs aid in improving wakefulness in adult patients and minimizing hallucinations, sleepiness and cataplexy.
Narcolepsy Drugs Market Trends:
The increasing prevalence of narcolepsy across the globe is one of the key factors driving the growth of the market. This can be attributed to the sedentary lifestyles and hectic schedules of the working population, which, in turn, is significantly increasing the incidences of sleep-related disorders. Moreover, rising health consciousness among the masses and the increasing awareness regarding the available treatment alternatives are providing a thrust to the market growth. In line with this, the widespread adoption of sodium oxybate for the treatment of narcolepsy in children is also contributing to the growth of the market. Additionally, significant improvements in the diagnostic technologies for narcolepsy are acting as other growth-inducing factors. Pharmaceutical manufacturers are also developing variants with long-term benefits and reduced side effects. Other factors, including the rising geriatric population, which is more susceptible to such ailments, along with extensive research and development (R&D) activities in the field of neurology, are anticipated to drive the market toward growth.
Key Market Segmentation:
IMARC Group provides an analysis of the key trends in each sub-segment of the global narcolepsy drugs market report, along with forecasts at the global, regional and country level from 2023-2028. Our report has categorized the market based on type, disease type and therapeutic type.
Breakup by Type:
Narcolepsy with Cataplexy
Narcolepsy without Cataplexy
Secondary Narcolepsy
Breakup by Disease Type:
Daytime Extreme Sleepiness
Cataplexia
Others
Breakup by Therapeutic Type:
Sodium Oxybate
Central Nervous System Stimulants
Tricyclic Antidepressants
Selective Serotonin Reuptake Inhibitor
Others
Breakup by Region:
North America
United States
Canada
Asia-Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa
Competitive Landscape:
The competitive landscape of the industry has also been examined along with the profiles of the key players being Avadel Pharmaceuticals plc, Axsome Therapeutics Inc., Bioprojet Pharma, Graymark Healthcare Inc., Jazz Pharmaceuticals plc, Ligand Pharmaceuticals Incorporated, Novartis AG, SHIONOGI & Co. Ltd., Takeda Pharmaceutical Company Limited and Teva Pharmaceutical Industries Ltd
Key Questions Answered in This Report:
How has the global narcolepsy drugs market performed so far and how will it perform in the coming years?
What has been the impact of COVID-19 on the global narcolepsy drugs market?
What are the key regional markets?
What is the breakup of the market based on the type?
What is the breakup of the market based on the disease type?
What is the breakup of the market based on the therapeutic type?
What are the various stages in the value chain of the industry?
What are the key driving factors and challenges in the industry?
What is the structure of the global narcolepsy drugs market and who are the key players?
What is the degree of competition in the industry?
The global narcolepsy drugs market size reached US$ 3.1 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 4.8 Billion by 2028, exhibiting a growth rate (CAGR) of 7.51% during 2023-2028.
Narcolepsy drugs refer to pharmaceutical medicines used for the treatment of chronic sleep disorders. The disorder is characterized by excessive daytime sleepiness (EDS), cataplexy or sudden loss of muscle strength, sleep paralysis, hallucinations, fragmented sleep and insomnia. Additional symptoms may include automatic behaviors without conscious awareness, blurred vision, double vision or droopy eyelids and disturbed mental functioning. Patients suffering from narcolepsy tend to sleep the same number of hours per day as normal individuals; however, sleep quality tends to be poorer. Some of the commonly used narcolepsy drugs include central nervous system stimulants, sodium oxybate, selective serotonin reuptake inhibitors and tricyclic antidepressants. These drugs aid in improving wakefulness in adult patients and minimizing hallucinations, sleepiness and cataplexy.
Narcolepsy Drugs Market Trends:
The increasing prevalence of narcolepsy across the globe is one of the key factors driving the growth of the market. This can be attributed to the sedentary lifestyles and hectic schedules of the working population, which, in turn, is significantly increasing the incidences of sleep-related disorders. Moreover, rising health consciousness among the masses and the increasing awareness regarding the available treatment alternatives are providing a thrust to the market growth. In line with this, the widespread adoption of sodium oxybate for the treatment of narcolepsy in children is also contributing to the growth of the market. Additionally, significant improvements in the diagnostic technologies for narcolepsy are acting as other growth-inducing factors. Pharmaceutical manufacturers are also developing variants with long-term benefits and reduced side effects. Other factors, including the rising geriatric population, which is more susceptible to such ailments, along with extensive research and development (R&D) activities in the field of neurology, are anticipated to drive the market toward growth.
Key Market Segmentation:
IMARC Group provides an analysis of the key trends in each sub-segment of the global narcolepsy drugs market report, along with forecasts at the global, regional and country level from 2023-2028. Our report has categorized the market based on type, disease type and therapeutic type.
Breakup by Type:
Narcolepsy with Cataplexy
Narcolepsy without Cataplexy
Secondary Narcolepsy
Breakup by Disease Type:
Daytime Extreme Sleepiness
Cataplexia
Others
Breakup by Therapeutic Type:
Sodium Oxybate
Central Nervous System Stimulants
Tricyclic Antidepressants
Selective Serotonin Reuptake Inhibitor
Others
Breakup by Region:
North America
United States
Canada
Asia-Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa
Competitive Landscape:
The competitive landscape of the industry has also been examined along with the profiles of the key players being Avadel Pharmaceuticals plc, Axsome Therapeutics Inc., Bioprojet Pharma, Graymark Healthcare Inc., Jazz Pharmaceuticals plc, Ligand Pharmaceuticals Incorporated, Novartis AG, SHIONOGI & Co. Ltd., Takeda Pharmaceutical Company Limited and Teva Pharmaceutical Industries Ltd
Key Questions Answered in This Report:
How has the global narcolepsy drugs market performed so far and how will it perform in the coming years?
What has been the impact of COVID-19 on the global narcolepsy drugs market?
What are the key regional markets?
What is the breakup of the market based on the type?
What is the breakup of the market based on the disease type?
What is the breakup of the market based on the therapeutic type?
What are the various stages in the value chain of the industry?
What are the key driving factors and challenges in the industry?
What is the structure of the global narcolepsy drugs market and who are the key players?
What is the degree of competition in the industry?
1 PREFACE
2 SCOPE AND METHODOLOGY
2.1Objectives of the Study
2.2Stakeholders
2.3Data Sources
2.3.1Primary Sources
2.3.2Secondary Sources
2.4Market Estimation
2.4.1Bottom-Up Approach
2.4.2Top-Down Approach
2.5Forecasting Methodology
3 EXECUTIVE SUMMARY
4 INTRODUCTION
4.1Overview
4.2Key Industry Trends
5 GLOBAL NARCOLEPSY DRUGS MARKET
5.1Market Overview
5.2Market Performance
5.3Impact of COVID-19
5.4Market Forecast
6 MARKET BREAKUP BY TYPE
6.1Narcolepsy with Cataplexy
6.1.1 Market Trends
6.1.2 Market Forecast
6.2Narcolepsy without Cataplexy
6.2.1 Market Trends
6.2.2 Market Forecast
6.3Secondary Narcolepsy
6.3.1 Market Trends
6.3.2 Market Forecast
7 MARKET BREAKUP BY DISEASE TYPE
7.1Daytime Extreme Sleepiness
7.1.1 Market Trends
7.1.2 Market Forecast
7.2Cataplexia
7.2.1 Market Trends
7.2.2 Market Forecast
7.3Others
7.3.1 Market Trends
7.3.2 Market Forecast
8 MARKET BREAKUP BY THERAPEUTIC TYPE
8.1Sodium Oxybate
8.1.1 Market Trends
8.1.2 Market Forecast
8.2Central Nervous System Stimulants
8.2.1 Market Trends
8.2.2 Market Forecast
8.3Tricyclic Antidepressants
8.3.1 Market Trends
8.3.2 Market Forecast
8.4Selective Serotonin Reuptake Inhibitor
8.4.1 Market Trends
8.4.2 Market Forecast
8.5Others
8.5.1 Market Trends
8.5.2 Market Forecast
9 MARKET BREAKUP BY REGION
9.1North America
9.1.1 United States
9.1.1.1 Market Trends
9.1.1.2 Market Forecast
9.1.2 Canada
9.1.2.1 Market Trends
9.1.2.2 Market Forecast
9.2Asia-Pacific
9.2.1 China
9.2.1.1 Market Trends
9.2.1.2 Market Forecast
9.2.2 Japan
9.2.2.1 Market Trends
9.2.2.2 Market Forecast
9.2.3 India
9.2.3.1 Market Trends
9.2.3.2 Market Forecast
9.2.4 South Korea
9.2.4.1 Market Trends
9.2.4.2 Market Forecast
9.2.5 Australia
9.2.5.1 Market Trends
9.2.5.2 Market Forecast
9.2.6 Indonesia
9.2.6.1 Market Trends
9.2.6.2 Market Forecast
9.2.7 Others
9.2.7.1 Market Trends
9.2.7.2 Market Forecast
9.3Europe
9.3.1 Germany
9.3.1.1 Market Trends
9.3.1.2 Market Forecast
9.3.2 France
9.3.2.1 Market Trends
9.3.2.2 Market Forecast
9.3.3 United Kingdom
9.3.3.1 Market Trends
9.3.3.2 Market Forecast
9.3.4 Italy
9.3.4.1 Market Trends
9.3.4.2 Market Forecast
9.3.5 Spain
9.3.5.1 Market Trends
9.3.5.2 Market Forecast
9.3.6 Russia
9.3.6.1 Market Trends
9.3.6.2 Market Forecast
9.3.7 Others
9.3.7.1 Market Trends
9.3.7.2 Market Forecast
9.4Latin America
9.4.1 Brazil
9.4.1.1 Market Trends
9.4.1.2 Market Forecast
9.4.2 Mexico
9.4.2.1 Market Trends
9.4.2.2 Market Forecast
9.4.3 Others
9.4.3.1 Market Trends
9.4.3.2 Market Forecast
9.5Middle East and Africa
9.5.1 Market Trends
9.5.2 Market Breakup by Country
9.5.3 Market Forecast
10 SWOT ANALYSIS
10.1Overview
10.2Strengths
10.3Weaknesses
10.4Opportunities
10.5Threats
11 VALUE CHAIN ANALYSIS
12 PORTERS FIVE FORCES ANALYSIS
12.1Overview
12.2Bargaining Power of Buyers
12.3Bargaining Power of Suppliers
12.4Degree of Competition
12.5Threat of New Entrants
12.6Threat of Substitutes
13 PRICE ANALYSIS
14 COMPETITIVE LANDSCAPE
14.1Market Structure
14.2Key Players
14.3Profiles of Key Players
14.3.1Avadel Pharmaceuticals plc
14.3.1.1 Company Overview
14.3.1.2 Product Portfolio
14.3.1.3 Financials
14.3.1.4 SWOT Analysis
14.3.2Axsome Therapeutics Inc.
14.3.2.1 Company Overview
14.3.2.2 Product Portfolio
14.3.2.3 Financials
14.3.3Bioprojet Pharma
14.3.3.1 Company Overview
14.3.3.2 Product Portfolio
14.3.4Graymark Healthcare Inc.
14.3.4.1 Company Overview
14.3.4.2 Product Portfolio
14.3.5Jazz Pharmaceuticals plc
14.3.5.1 Company Overview
14.3.5.2 Product Portfolio
14.3.5.3 Financials
14.3.5.4 SWOT Analysis
14.3.6Ligand Pharmaceuticals Incorporated
14.3.6.1 Company Overview
14.3.6.2 Product Portfolio
14.3.6.3 Financials
14.3.6.4 SWOT Analysis
14.3.7Novartis AG
14.3.7.1 Company Overview
14.3.7.2 Product Portfolio
14.3.7.3 Financials
14.3.7.4 SWOT Analysis
14.3.8SHIONOGI & Co. Ltd.
14.3.8.1 Company Overview
14.3.8.2 Product Portfolio
14.3.8.3 Financials
14.3.8.4 SWOT Analysis
14.3.9Takeda Pharmaceutical Company Limited
14.3.9.1 Company Overview
14.3.9.2 Product Portfolio
14.3.9.3 Financials
14.3.9.4 SWOT Analysis
14.3.10Teva Pharmaceutical Industries Ltd.
14.3.10.1 Company Overview
14.3.10.2 Product Portfolio
14.3.10.3 Financials
14.3.10.4 SWOT Analysis
2 SCOPE AND METHODOLOGY
2.1Objectives of the Study
2.2Stakeholders
2.3Data Sources
2.3.1Primary Sources
2.3.2Secondary Sources
2.4Market Estimation
2.4.1Bottom-Up Approach
2.4.2Top-Down Approach
2.5Forecasting Methodology
3 EXECUTIVE SUMMARY
4 INTRODUCTION
4.1Overview
4.2Key Industry Trends
5 GLOBAL NARCOLEPSY DRUGS MARKET
5.1Market Overview
5.2Market Performance
5.3Impact of COVID-19
5.4Market Forecast
6 MARKET BREAKUP BY TYPE
6.1Narcolepsy with Cataplexy
6.1.1 Market Trends
6.1.2 Market Forecast
6.2Narcolepsy without Cataplexy
6.2.1 Market Trends
6.2.2 Market Forecast
6.3Secondary Narcolepsy
6.3.1 Market Trends
6.3.2 Market Forecast
7 MARKET BREAKUP BY DISEASE TYPE
7.1Daytime Extreme Sleepiness
7.1.1 Market Trends
7.1.2 Market Forecast
7.2Cataplexia
7.2.1 Market Trends
7.2.2 Market Forecast
7.3Others
7.3.1 Market Trends
7.3.2 Market Forecast
8 MARKET BREAKUP BY THERAPEUTIC TYPE
8.1Sodium Oxybate
8.1.1 Market Trends
8.1.2 Market Forecast
8.2Central Nervous System Stimulants
8.2.1 Market Trends
8.2.2 Market Forecast
8.3Tricyclic Antidepressants
8.3.1 Market Trends
8.3.2 Market Forecast
8.4Selective Serotonin Reuptake Inhibitor
8.4.1 Market Trends
8.4.2 Market Forecast
8.5Others
8.5.1 Market Trends
8.5.2 Market Forecast
9 MARKET BREAKUP BY REGION
9.1North America
9.1.1 United States
9.1.1.1 Market Trends
9.1.1.2 Market Forecast
9.1.2 Canada
9.1.2.1 Market Trends
9.1.2.2 Market Forecast
9.2Asia-Pacific
9.2.1 China
9.2.1.1 Market Trends
9.2.1.2 Market Forecast
9.2.2 Japan
9.2.2.1 Market Trends
9.2.2.2 Market Forecast
9.2.3 India
9.2.3.1 Market Trends
9.2.3.2 Market Forecast
9.2.4 South Korea
9.2.4.1 Market Trends
9.2.4.2 Market Forecast
9.2.5 Australia
9.2.5.1 Market Trends
9.2.5.2 Market Forecast
9.2.6 Indonesia
9.2.6.1 Market Trends
9.2.6.2 Market Forecast
9.2.7 Others
9.2.7.1 Market Trends
9.2.7.2 Market Forecast
9.3Europe
9.3.1 Germany
9.3.1.1 Market Trends
9.3.1.2 Market Forecast
9.3.2 France
9.3.2.1 Market Trends
9.3.2.2 Market Forecast
9.3.3 United Kingdom
9.3.3.1 Market Trends
9.3.3.2 Market Forecast
9.3.4 Italy
9.3.4.1 Market Trends
9.3.4.2 Market Forecast
9.3.5 Spain
9.3.5.1 Market Trends
9.3.5.2 Market Forecast
9.3.6 Russia
9.3.6.1 Market Trends
9.3.6.2 Market Forecast
9.3.7 Others
9.3.7.1 Market Trends
9.3.7.2 Market Forecast
9.4Latin America
9.4.1 Brazil
9.4.1.1 Market Trends
9.4.1.2 Market Forecast
9.4.2 Mexico
9.4.2.1 Market Trends
9.4.2.2 Market Forecast
9.4.3 Others
9.4.3.1 Market Trends
9.4.3.2 Market Forecast
9.5Middle East and Africa
9.5.1 Market Trends
9.5.2 Market Breakup by Country
9.5.3 Market Forecast
10 SWOT ANALYSIS
10.1Overview
10.2Strengths
10.3Weaknesses
10.4Opportunities
10.5Threats
11 VALUE CHAIN ANALYSIS
12 PORTERS FIVE FORCES ANALYSIS
12.1Overview
12.2Bargaining Power of Buyers
12.3Bargaining Power of Suppliers
12.4Degree of Competition
12.5Threat of New Entrants
12.6Threat of Substitutes
13 PRICE ANALYSIS
14 COMPETITIVE LANDSCAPE
14.1Market Structure
14.2Key Players
14.3Profiles of Key Players
14.3.1Avadel Pharmaceuticals plc
14.3.1.1 Company Overview
14.3.1.2 Product Portfolio
14.3.1.3 Financials
14.3.1.4 SWOT Analysis
14.3.2Axsome Therapeutics Inc.
14.3.2.1 Company Overview
14.3.2.2 Product Portfolio
14.3.2.3 Financials
14.3.3Bioprojet Pharma
14.3.3.1 Company Overview
14.3.3.2 Product Portfolio
14.3.4Graymark Healthcare Inc.
14.3.4.1 Company Overview
14.3.4.2 Product Portfolio
14.3.5Jazz Pharmaceuticals plc
14.3.5.1 Company Overview
14.3.5.2 Product Portfolio
14.3.5.3 Financials
14.3.5.4 SWOT Analysis
14.3.6Ligand Pharmaceuticals Incorporated
14.3.6.1 Company Overview
14.3.6.2 Product Portfolio
14.3.6.3 Financials
14.3.6.4 SWOT Analysis
14.3.7Novartis AG
14.3.7.1 Company Overview
14.3.7.2 Product Portfolio
14.3.7.3 Financials
14.3.7.4 SWOT Analysis
14.3.8SHIONOGI & Co. Ltd.
14.3.8.1 Company Overview
14.3.8.2 Product Portfolio
14.3.8.3 Financials
14.3.8.4 SWOT Analysis
14.3.9Takeda Pharmaceutical Company Limited
14.3.9.1 Company Overview
14.3.9.2 Product Portfolio
14.3.9.3 Financials
14.3.9.4 SWOT Analysis
14.3.10Teva Pharmaceutical Industries Ltd.
14.3.10.1 Company Overview
14.3.10.2 Product Portfolio
14.3.10.3 Financials
14.3.10.4 SWOT Analysis
LIST OF TABLES
Table 1: Global: Narcolepsy Drugs Market: Key Industry Highlights, 2022 and 2028
Table 2: Global: Narcolepsy Drugs Market Forecast: Breakup by Type (in Million US$), 2023-2028
Table 3: Global: Narcolepsy Drugs Market Forecast: Breakup by Disease Type (in Million US$), 2023-2028
Table 4: Global: Narcolepsy Drugs Market Forecast: Breakup by Therapeutic Type (in Million US$), 2023-2028
Table 5: Global: Narcolepsy Drugs Market Forecast: Breakup by Region (in Million US$), 2023-2028
Table 6: Global: Narcolepsy Drugs Market: Competitive Structure
Table 7: Global: Narcolepsy Drugs Market: Key Players
Table 1: Global: Narcolepsy Drugs Market: Key Industry Highlights, 2022 and 2028
Table 2: Global: Narcolepsy Drugs Market Forecast: Breakup by Type (in Million US$), 2023-2028
Table 3: Global: Narcolepsy Drugs Market Forecast: Breakup by Disease Type (in Million US$), 2023-2028
Table 4: Global: Narcolepsy Drugs Market Forecast: Breakup by Therapeutic Type (in Million US$), 2023-2028
Table 5: Global: Narcolepsy Drugs Market Forecast: Breakup by Region (in Million US$), 2023-2028
Table 6: Global: Narcolepsy Drugs Market: Competitive Structure
Table 7: Global: Narcolepsy Drugs Market: Key Players
LIST OF FIGURES
Figure 1: Global: Narcolepsy Drugs Market: Major Drivers and Challenges
Figure 2: Global: Narcolepsy Drugs Market: Sales Value (in Billion US$), 2017-2022
Figure 3: Global: Narcolepsy Drugs Market Forecast: Sales Value (in Billion US$), 2023-2028
Figure 4: Global: Narcolepsy Drugs Market: Breakup by Type (in %), 2022
Figure 5: Global: Narcolepsy Drugs Market: Breakup by Disease Type (in %), 2022
Figure 6: Global: Narcolepsy Drugs Market: Breakup by Therapeutic Type (in %), 2022
Figure 7: Global: Narcolepsy Drugs Market: Breakup by Region (in %), 2022
Figure 8: Global: Narcolepsy Drugs (Narcolepsy with Cataplexy) Market: Sales Value (in Million US$), 2017 & 2022
Figure 9: Global: Narcolepsy Drugs (Narcolepsy with Cataplexy) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 10: Global: Narcolepsy Drugs (Narcolepsy without Cataplexy) Market: Sales Value (in Million US$), 2017 & 2022
Figure 11: Global: Narcolepsy Drugs (Narcolepsy without Cataplexy) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 12: Global: Narcolepsy Drugs (Secondary Narcolepsy) Market: Sales Value (in Million US$), 2017 & 2022
Figure 13: Global: Narcolepsy Drugs (Secondary Narcolepsy) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 14: Global: Narcolepsy Drugs (Daytime Extreme Sleepiness) Market: Sales Value (in Million US$), 2017 & 2022
Figure 15: Global: Narcolepsy Drugs (Daytime Extreme Sleepiness) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 16: Global: Narcolepsy Drugs (Cataplexia) Market: Sales Value (in Million US$), 2017 & 2022
Figure 17: Global: Narcolepsy Drugs (Cataplexia) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 18: Global: Narcolepsy Drugs (Other Disease Types) Market: Sales Value (in Million US$), 2017 & 2022
Figure 19: Global: Narcolepsy Drugs (Other Disease Types) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 20: Global: Narcolepsy Drugs (Sodium Oxybate) Market: Sales Value (in Million US$), 2017 & 2022
Figure 21: Global: Narcolepsy Drugs (Sodium Oxybate) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 22: Global: Narcolepsy Drugs (Central Nervous System Stimulants) Market: Sales Value (in Million US$), 2017 & 2022
Figure 23: Global: Narcolepsy Drugs (Central Nervous System Stimulants) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 24: Global: Narcolepsy Drugs (Tricyclic Antidepressants) Market: Sales Value (in Million US$), 2017 & 2022
Figure 25: Global: Narcolepsy Drugs (Tricyclic Antidepressants) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 26: Global: Narcolepsy Drugs (Selective Serotonin Reuptake Inhibitor) Market: Sales Value (in Million US$), 2017 & 2022
Figure 27: Global: Narcolepsy Drugs (Selective Serotonin Reuptake Inhibitor) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 28: Global: Narcolepsy Drugs (Other Therapeutic Types) Market: Sales Value (in Million US$), 2017 & 2022
Figure 29: Global: Narcolepsy Drugs (Other Therapeutic Types) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 30: North America: Narcolepsy Drugs Market: Sales Value (in Million US$), 2017 & 2022
Figure 31: North America: Narcolepsy Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 32: United States: Narcolepsy Drugs Market: Sales Value (in Million US$), 2017 & 2022
Figure 33: United States: Narcolepsy Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 34: Canada: Narcolepsy Drugs Market: Sales Value (in Million US$), 2017 & 2022
Figure 35: Canada: Narcolepsy Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 36: Asia-Pacific: Narcolepsy Drugs Market: Sales Value (in Million US$), 2017 & 2022
Figure 37: Asia-Pacific: Narcolepsy Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 38: China: Narcolepsy Drugs Market: Sales Value (in Million US$), 2017 & 2022
Figure 39: China: Narcolepsy Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 40: Japan: Narcolepsy Drugs Market: Sales Value (in Million US$), 2017 & 2022
Figure 41: Japan: Narcolepsy Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 42: India: Narcolepsy Drugs Market: Sales Value (in Million US$), 2017 & 2022
Figure 43: India: Narcolepsy Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 44: South Korea: Narcolepsy Drugs Market: Sales Value (in Million US$), 2017 & 2022
Figure 45: South Korea: Narcolepsy Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 46: Australia: Narcolepsy Drugs Market: Sales Value (in Million US$), 2017 & 2022
Figure 47: Australia: Narcolepsy Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 48: Indonesia: Narcolepsy Drugs Market: Sales Value (in Million US$), 2017 & 2022
Figure 49: Indonesia: Narcolepsy Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 50: Others: Narcolepsy Drugs Market: Sales Value (in Million US$), 2017 & 2022
Figure 51: Others: Narcolepsy Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 52: Europe: Narcolepsy Drugs Market: Sales Value (in Million US$), 2017 & 2022
Figure 53: Europe: Narcolepsy Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 54: Germany: Narcolepsy Drugs Market: Sales Value (in Million US$), 2017 & 2022
Figure 55: Germany: Narcolepsy Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 56: France: Narcolepsy Drugs Market: Sales Value (in Million US$), 2017 & 2022
Figure 57: France: Narcolepsy Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 58: United Kingdom: Narcolepsy Drugs Market: Sales Value (in Million US$), 2017 & 2022
Figure 59: United Kingdom: Narcolepsy Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 60: Italy: Narcolepsy Drugs Market: Sales Value (in Million US$), 2017 & 2022
Figure 61: Italy: Narcolepsy Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 62: Spain: Narcolepsy Drugs Market: Sales Value (in Million US$), 2017 & 2022
Figure 63: Spain: Narcolepsy Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 64: Russia: Narcolepsy Drugs Market: Sales Value (in Million US$), 2017 & 2022
Figure 65: Russia: Narcolepsy Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 66: Others: Narcolepsy Drugs Market: Sales Value (in Million US$), 2017 & 2022
Figure 67: Others: Narcolepsy Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 68: Latin America: Narcolepsy Drugs Market: Sales Value (in Million US$), 2017 & 2022
Figure 69: Latin America: Narcolepsy Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 70: Brazil: Narcolepsy Drugs Market: Sales Value (in Million US$), 2017 & 2022
Figure 71: Brazil: Narcolepsy Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 72: Mexico: Narcolepsy Drugs Market: Sales Value (in Million US$), 2017 & 2022
Figure 73: Mexico: Narcolepsy Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 74: Others: Narcolepsy Drugs Market: Sales Value (in Million US$), 2017 & 2022
Figure 75: Others: Narcolepsy Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 76: Middle East and Africa: Narcolepsy Drugs Market: Sales Value (in Million US$), 2017 & 2022
Figure 77: Middle East and Africa: Narcolepsy Drugs Market: Breakup by Country (in %), 2022
Figure 78: Middle East and Africa: Narcolepsy Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 79: Global: Narcolepsy Drugs Industry: SWOT Analysis
Figure 80: Global: Narcolepsy Drugs Industry: Value Chain Analysis
Figure 81: Global: Narcolepsy Drugs Industry: Porter's Five Forces Analysis
Figure 1: Global: Narcolepsy Drugs Market: Major Drivers and Challenges
Figure 2: Global: Narcolepsy Drugs Market: Sales Value (in Billion US$), 2017-2022
Figure 3: Global: Narcolepsy Drugs Market Forecast: Sales Value (in Billion US$), 2023-2028
Figure 4: Global: Narcolepsy Drugs Market: Breakup by Type (in %), 2022
Figure 5: Global: Narcolepsy Drugs Market: Breakup by Disease Type (in %), 2022
Figure 6: Global: Narcolepsy Drugs Market: Breakup by Therapeutic Type (in %), 2022
Figure 7: Global: Narcolepsy Drugs Market: Breakup by Region (in %), 2022
Figure 8: Global: Narcolepsy Drugs (Narcolepsy with Cataplexy) Market: Sales Value (in Million US$), 2017 & 2022
Figure 9: Global: Narcolepsy Drugs (Narcolepsy with Cataplexy) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 10: Global: Narcolepsy Drugs (Narcolepsy without Cataplexy) Market: Sales Value (in Million US$), 2017 & 2022
Figure 11: Global: Narcolepsy Drugs (Narcolepsy without Cataplexy) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 12: Global: Narcolepsy Drugs (Secondary Narcolepsy) Market: Sales Value (in Million US$), 2017 & 2022
Figure 13: Global: Narcolepsy Drugs (Secondary Narcolepsy) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 14: Global: Narcolepsy Drugs (Daytime Extreme Sleepiness) Market: Sales Value (in Million US$), 2017 & 2022
Figure 15: Global: Narcolepsy Drugs (Daytime Extreme Sleepiness) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 16: Global: Narcolepsy Drugs (Cataplexia) Market: Sales Value (in Million US$), 2017 & 2022
Figure 17: Global: Narcolepsy Drugs (Cataplexia) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 18: Global: Narcolepsy Drugs (Other Disease Types) Market: Sales Value (in Million US$), 2017 & 2022
Figure 19: Global: Narcolepsy Drugs (Other Disease Types) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 20: Global: Narcolepsy Drugs (Sodium Oxybate) Market: Sales Value (in Million US$), 2017 & 2022
Figure 21: Global: Narcolepsy Drugs (Sodium Oxybate) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 22: Global: Narcolepsy Drugs (Central Nervous System Stimulants) Market: Sales Value (in Million US$), 2017 & 2022
Figure 23: Global: Narcolepsy Drugs (Central Nervous System Stimulants) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 24: Global: Narcolepsy Drugs (Tricyclic Antidepressants) Market: Sales Value (in Million US$), 2017 & 2022
Figure 25: Global: Narcolepsy Drugs (Tricyclic Antidepressants) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 26: Global: Narcolepsy Drugs (Selective Serotonin Reuptake Inhibitor) Market: Sales Value (in Million US$), 2017 & 2022
Figure 27: Global: Narcolepsy Drugs (Selective Serotonin Reuptake Inhibitor) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 28: Global: Narcolepsy Drugs (Other Therapeutic Types) Market: Sales Value (in Million US$), 2017 & 2022
Figure 29: Global: Narcolepsy Drugs (Other Therapeutic Types) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 30: North America: Narcolepsy Drugs Market: Sales Value (in Million US$), 2017 & 2022
Figure 31: North America: Narcolepsy Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 32: United States: Narcolepsy Drugs Market: Sales Value (in Million US$), 2017 & 2022
Figure 33: United States: Narcolepsy Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 34: Canada: Narcolepsy Drugs Market: Sales Value (in Million US$), 2017 & 2022
Figure 35: Canada: Narcolepsy Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 36: Asia-Pacific: Narcolepsy Drugs Market: Sales Value (in Million US$), 2017 & 2022
Figure 37: Asia-Pacific: Narcolepsy Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 38: China: Narcolepsy Drugs Market: Sales Value (in Million US$), 2017 & 2022
Figure 39: China: Narcolepsy Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 40: Japan: Narcolepsy Drugs Market: Sales Value (in Million US$), 2017 & 2022
Figure 41: Japan: Narcolepsy Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 42: India: Narcolepsy Drugs Market: Sales Value (in Million US$), 2017 & 2022
Figure 43: India: Narcolepsy Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 44: South Korea: Narcolepsy Drugs Market: Sales Value (in Million US$), 2017 & 2022
Figure 45: South Korea: Narcolepsy Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 46: Australia: Narcolepsy Drugs Market: Sales Value (in Million US$), 2017 & 2022
Figure 47: Australia: Narcolepsy Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 48: Indonesia: Narcolepsy Drugs Market: Sales Value (in Million US$), 2017 & 2022
Figure 49: Indonesia: Narcolepsy Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 50: Others: Narcolepsy Drugs Market: Sales Value (in Million US$), 2017 & 2022
Figure 51: Others: Narcolepsy Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 52: Europe: Narcolepsy Drugs Market: Sales Value (in Million US$), 2017 & 2022
Figure 53: Europe: Narcolepsy Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 54: Germany: Narcolepsy Drugs Market: Sales Value (in Million US$), 2017 & 2022
Figure 55: Germany: Narcolepsy Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 56: France: Narcolepsy Drugs Market: Sales Value (in Million US$), 2017 & 2022
Figure 57: France: Narcolepsy Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 58: United Kingdom: Narcolepsy Drugs Market: Sales Value (in Million US$), 2017 & 2022
Figure 59: United Kingdom: Narcolepsy Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 60: Italy: Narcolepsy Drugs Market: Sales Value (in Million US$), 2017 & 2022
Figure 61: Italy: Narcolepsy Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 62: Spain: Narcolepsy Drugs Market: Sales Value (in Million US$), 2017 & 2022
Figure 63: Spain: Narcolepsy Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 64: Russia: Narcolepsy Drugs Market: Sales Value (in Million US$), 2017 & 2022
Figure 65: Russia: Narcolepsy Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 66: Others: Narcolepsy Drugs Market: Sales Value (in Million US$), 2017 & 2022
Figure 67: Others: Narcolepsy Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 68: Latin America: Narcolepsy Drugs Market: Sales Value (in Million US$), 2017 & 2022
Figure 69: Latin America: Narcolepsy Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 70: Brazil: Narcolepsy Drugs Market: Sales Value (in Million US$), 2017 & 2022
Figure 71: Brazil: Narcolepsy Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 72: Mexico: Narcolepsy Drugs Market: Sales Value (in Million US$), 2017 & 2022
Figure 73: Mexico: Narcolepsy Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 74: Others: Narcolepsy Drugs Market: Sales Value (in Million US$), 2017 & 2022
Figure 75: Others: Narcolepsy Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 76: Middle East and Africa: Narcolepsy Drugs Market: Sales Value (in Million US$), 2017 & 2022
Figure 77: Middle East and Africa: Narcolepsy Drugs Market: Breakup by Country (in %), 2022
Figure 78: Middle East and Africa: Narcolepsy Drugs Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 79: Global: Narcolepsy Drugs Industry: SWOT Analysis
Figure 80: Global: Narcolepsy Drugs Industry: Value Chain Analysis
Figure 81: Global: Narcolepsy Drugs Industry: Porter's Five Forces Analysis
